TG Therapeutics, Inc.
TGTX
$28.53
$0.572.04%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -94.11% | 1,286.79% | 457.06% | -78.31% | 501.31% |
| Total Depreciation and Amortization | 23.53% | 30.77% | 62.50% | -11.11% | -18.18% |
| Total Amortization of Deferred Charges | 0.29% | -0.29% | -0.57% | -1.12% | -23.77% |
| Total Other Non-Cash Items | 111.67% | -2,337.81% | 8.48% | 26.34% | -25.29% |
| Change in Net Operating Assets | 31.17% | -76.13% | 24.31% | 20.08% | -90.86% |
| Cash from Operations | 184.91% | -411.36% | 125.90% | -11.99% | -110.09% |
| Capital Expenditure | 16.25% | -90.48% | -68.00% | -19.05% | 12.50% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -133.53% | 1,275.77% | 69.40% | -181.66% | 269.81% |
| Cash from Investing | -133.73% | 1,261.40% | 69.14% | -181.92% | 269.15% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | 100.00% |
| Issuance of Common Stock | -- | -100.00% | 1,957.14% | -96.32% | 186.43% |
| Repurchase of Common Stock | 100.00% | -1,038.07% | -12.28% | 7.38% | -207.63% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 96.39% |
| Cash from Financing | 101.35% | -1,114.37% | -5.59% | -0.49% | -104.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 109.23% | -1,735.01% | 93.72% | -199.85% | -114.10% |